OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Salem on the Role of Locoregional Therapy in HCC

April 14th 2020

Riad Salem, MD, discusses the role of locoregional therapy in hepatocellular carcinoma.

Dr. Katz on Neoadjuvant Chemotherapy in Pancreatic Cancer

April 14th 2020

Matthew H.G. Katz, MD, FACS, discusses the benefit of neoadjuvant chemotherapy in patients with pancreatic cancer.

Dr. Hwang on the Utility of Antiandrogens in Metastatic Prostate Cancer

April 14th 2020

Clara Hwang, MD, discusses the utility of antiandrogens in patients with metastatic prostate cancer.

Dr. Schmaier on the Secondary Management of Thrombosis in Hematologic Malignancies

April 14th 2020

Alvin H. Schmaier, MD, discusses the secondary management of thrombosis in patients with hematologic malignancies.

Dr. Reckamp on Navigating Challenges Posed by COVID-19

April 14th 2020

Karen L. Reckamp, MD, MS, provides insight on how she is navigating challenges posed by the COVID-19 crisis.

Dr. Davies on Promise of Venetoclax in Relapsed/Refractory Myeloma

April 13th 2020

Faith E. Davies, MD, discusses the use of venetoclax as a precision medicine approach in patients with relapsed/refractory multiple myeloma.

Dr. Graff on Genomic Risk Prediction in HR+/HER2- Breast Cancer

April 11th 2020

Stephanie L. Graff, MD, discusses genomic risk prediction in patients with hormone receptor–positive, HER2-negative breast cancer.

Dr. Abou-Alfa on Sequencing Challenges in Metastatic HCC

April 11th 2020

Ghassan K. Abou-Alfa, MD, discusses sequencing challenges in metastatic hepatocellular carcinoma.

Dr. Patel on Data From the MEDALIST Trial in Low-Risk MDS

April 11th 2020

Prapti Patel, MD, discusses data from the MEDALIST trial on the use of luspatercept-aamt in patients with low-risk myelodysplastic syndromes.

Dr. Hamid on Promising Triplet Combinations Under Exploration in Melanoma

April 11th 2020

Omid Hamid, MD, discusses promising triplet combination under exploration in melanoma.

Dr. D'Amato on the Emerging Role of Next-Generation Sequencing in Sarcoma

April 11th 2020

Gina Z. D'Amato, MD, discusses the emerging role of next-generation sequencing in sarcoma.

Dr. Mesa on Unanswered Questions Regarding JAK Inhibitors in Myelofibrosis

April 11th 2020

Ruben Mesa, MD, discusses unanswered questions regarding JAK inhibitors in myelofibrosis.

Dr. Chase on Toxicities With Niraparib in Ovarian Cancer

April 11th 2020

Dana Chase, MD, FACOG, discusses the safety profile of niraparib as frontline maintenance therapy in ovarian cancer.

Dr. Tagawa on Targeting PSMA in Prostate Cancer

April 10th 2020

Scott T. Tagawa, MD, MS, discusses the utility of beta and alpha emitters in targeting PSMA in prostate cancer.

Dr. Armstrong on the Utility of Pamiparib and Other PARP Inhibitors in Prostate Cancer

April 10th 2020

Andrew J. Armstrong, MD, discusses the utility of pamiparib and other PARP inhibitors in prostate cancer.

Dr. Rossetti on the Fast Track Designation of Momelotinib in Myelofibrosis

April 10th 2020

James M. Rossetti, DO, discusses the FDA’s decision to grant momelotinib a fast track designation for use in patients with intermediate- or high-risk myelofibrosis who previously received a JAK inhibitor.

Dr. Michaelis on Unanswered Questions in Myelofibrosis Treatment

April 10th 2020

Laura C. Michaelis, MD, discusses the direction of future myelofibrosis research.

Dr. Bekaii-Saab on the Impact of COVID-19 on Telemedicine

April 10th 2020

Tanios S. Bekaii-Saab, MD, FACP, discusses the impact of the novel coronavirus 2019 on telemedicine.

Dr. Chung on the Importance of Genomic Testing in Pancreatic Cancer

April 9th 2020

Vincent Chung, MD, discusses the importance of genomic testing in pancreatic cancer.

Dr. Woyach on the Utility of Time-Limited Therapies in CLL

April 9th 2020

Jennifer Woyach, MD, discusses the utility of time-limited therapies in chronic lymphocytic leukemia.